These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32563307)

  • 41. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can insight be predicted in first-episode psychosis patients? A longitudinal and hierarchical analysis of predictors in a drug-naïve sample.
    Cuesta MJ; Peralta V; Campos MS; Garcia-Jalon E
    Schizophr Res; 2011 Aug; 130(1-3):148-56. PubMed ID: 21632216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-level predictors and clinical correlates of duration of untreated psychosis among hospitalized first-episode patients.
    Compton MT; Gordon TL; Goulding SM; Esterberg ML; Carter T; Leiner AS; Weiss PS; Druss BG; Walker EF; Kaslow NJ
    J Clin Psychiatry; 2011 Feb; 72(2):225-32. PubMed ID: 21382306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: a systematic review and meta analysis.
    Farooq S; Large M; Nielssen O; Waheed W
    Schizophr Res; 2009 Apr; 109(1-3):15-23. PubMed ID: 19233621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duration of untreated psychosis: a proposition regarding treatment definition.
    Polari A; Lavoie S; Sarrasin P; Pellanda V; Cotton S; Conus P
    Early Interv Psychiatry; 2011 Nov; 5(4):301-8. PubMed ID: 22032548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Duration of Untreated Psychosis Correlates With Brain Connectivity and Morphology in Medication-Naïve Patients With First-Episode Psychosis.
    Maximo JO; Nelson EA; Armstrong WP; Kraguljac NV; Lahti AC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2020 Feb; 5(2):231-238. PubMed ID: 31902581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early premorbid adjustment as a moderator of the impact of duration of untreated psychosis.
    Norman RM; Malla AK; Manchanda R
    Schizophr Res; 2007 Sep; 95(1-3):111-4. PubMed ID: 17628442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metacognitive functioning predicts positive and negative symptoms over 12 months in first episode psychosis.
    McLeod HJ; Gumley AI; Macbeth A; Schwannauer M; Lysaker PH
    J Psychiatr Res; 2014 Jul; 54():109-15. PubMed ID: 24725651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duration of untreated psychosis: Impact of the definition of treatment onset on its predictive value over three years of treatment.
    Golay P; Alameda L; Baumann P; Elowe J; Progin P; Polari A; Conus P
    J Psychiatr Res; 2016 Jun; 77():15-21. PubMed ID: 26950643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study.
    Crespo-Facorro B; de la Foz VO; Ayesa-Arriola R; Pérez-Iglesias R; Mata I; Suarez-Pinilla P; Tabares-Seisdedos R; Vázquez-Barquero JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():162-7. PubMed ID: 23435091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does treatment delay predict occupational functioning in first-episode psychosis?
    Norman RM; Mallal AK; Manchanda R; Windell D; Harricharan R; Takhar J; Northcott S
    Schizophr Res; 2007 Mar; 91(1-3):259-62. PubMed ID: 17291725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Duration of Untreated Psychosis in Community Treatment Settings in the United States.
    Addington J; Heinssen RK; Robinson DG; Schooler NR; Marcy P; Brunette MF; Correll CU; Estroff S; Mueser KT; Penn D; Robinson JA; Rosenheck RA; Azrin ST; Goldstein AB; Severe J; Kane JM
    Psychiatr Serv; 2015 Jul; 66(7):753-6. PubMed ID: 25588418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.
    Galderisi S; Mucci A; Bitter I; Libiger J; Bucci P; Fleischhacker WW; Kahn RS;
    Eur Neuropsychopharmacol; 2013 Mar; 23(3):196-204. PubMed ID: 22647933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and demographic correlates of stigma in first-episode psychosis: the impact of duration of untreated psychosis.
    Mueser KT; DeTore NR; Kredlow MA; Bourgeois ML; Penn DL; Hintz K
    Acta Psychiatr Scand; 2020 Feb; 141(2):157-166. PubMed ID: 31557309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms.
    Ricci V; Martinotti G; Ceci F; Chiappini S; Di Carlo F; Burkauskas J; Susini O; Luciani D; Quattrone D; De Berardis D; Pettorruso M; Maina G; Di Giannantonio M
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
    O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
    Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trajectories and antecedents of treatment response over time in early-episode psychosis.
    Levine SZ; Rabinowitz J
    Schizophr Bull; 2010 May; 36(3):624-32. PubMed ID: 18849294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis.
    Larsen TK; Moe LC; Vibe-Hansen L; Johannessen JO
    Schizophr Res; 2000 Sep; 45(1-2):1-9. PubMed ID: 10978867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The association between pre-morbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis.
    Jeppesen P; Petersen L; Thorup A; Abel MB; Øhlenschlaeger J; Christensen TØ; Krarup G; Jørgensen P; Nordentoft M
    Psychol Med; 2008 Aug; 38(8):1157-66. PubMed ID: 18447961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.